Illinois Burning the midnight oil

Southern Illinois IL

AbbVie Presents New Late-Breaking Data Analyses Showing Risankizumab (SKYRIZI) Achieves Clinical Remission and Endoscopic Response at Week 12 in Patients with...

Mount Carmel Register

May 24, 2021

AbbVie Presents New Late-Breaking Data Analyses Showing Risankizumab (SKYRIZI) Achieves Clinical Remission and Endoscopic Response at Week 12 in Patients with Moderate to Severe Cr…

Read the full story at Mount Carmel Register

Related places

Mount Carmel

Topics

#AbbVie

More from Southern Illinois

FOX News on Illinois

Wealthy elites bankroll Dem Senate candidate who has repeatedly touted 'grassroots' campaign

Southern Illinois • Mar 4, 2026

Southern Illinois University Carbondale

Former Barrington Village President Darch receives 2025 Simon-Edgar Award

Southern Illinois • Aug 6, 2025

Southern Illinois University Carbondale

SIU Carbondale again earns national honors for assisting transfer students

Southern Illinois • Aug 6, 2025

Southern Illinois University Carbondale

Businesses, students and alumni welcome at SIU's Fall Job and Internship Fair

Southern Illinois • Aug 6, 2025

East Central Reporter

Clay County Hospital names Samantha Deain August Employee of the Month

Southern Illinois • Aug 6, 2025

Mount Carmel Register

'Not backing down': activists block hydro plants in N.Macedonia

Southern Illinois • Aug 6, 2025

Mount Carmel Register

Steeper US tariffs take effect on many Brazilian goods

Southern Illinois • Aug 6, 2025

Mount Carmel Register

Bangladesh mystic singers face Islamist backlash

Southern Illinois • Aug 6, 2025